{"id":54218,"title":"[Heterogeneity of epithelial ovarian carcinomas and their clinical significance].","abstract":"Le cancer épithélial de l'ovaire, malgré des thérapies améliorées, est une des tumeurs gynécologiques ayant une létalité très elevée. De nouvelles études génétiques moléculaires indiquent qu'il s'agit d'une maladie hétérogène, ce qui se reflète également dans les différents types histologiques des tumeurs. Les sous-types diffèrent par leur origine, les voies de développement et des altérations moléculaires et sont divisés en deux types principaux. Le carcinome de type I (low-grade) développe dans graduellement à partir de lésions précancéreuses alors que le carcinome de type II (high-grade), qui se développe rapidement sans lésions précurseurs évidentes. Les sous-types se distinguent par leur comportement biologique, ce qui a des répercussions sur le pronostic et le traitement et sera d'importance pour de futures thérapies personnalisées.Das epitheliale Ovarialkarzinom gehört trotz verbesserter Therapien zu den gynäkologischen Tumoren mit der höchsten Letalität. Neue molekulargenetische Untersuchungen belegen, dass es sich um eine heterogene Erkrankung handelt, die sich auch in den verschiedenen histologischen Tumortypen widerspiegelt. Die Subtypen unterscheiden sich in ihrem Ursprung, Entstehungswegen und molekularen Alterationen und werden in zwei Haupttypen eingeteilt. Das Typ-I-Karzinom (low-grade), das in einem schrittweisen Prozess über Vorläuferläsionen entsteht und das Typ-II-Karzinom (high-grade), das sich rasch und ohne eindeutige Vorläuferläsionen entwickelt. Die Subtypen unterscheiden sich weiterhin in ihrem biologischen Verhalten, was Auswirkungen auf die Prognose und Behandlung hat und für zukünftige personalisierte Therapien von Bedeutung sein wird.Epithelial ovarian cancer is one of the most lethal gynecological malignant tumors despite improvement of the treatment. Recent molecular studies show that ovarian cancer is a heterogeneous disease which is reflected by different histologic types. These subtypes differ from their origin, pathogenesis and molecular alterations and can be divided in two major groups. The type I cancer (low grade) evolves from precursor lesions in a step-wise process. In contrast, the type II cancer (high grade) grows rapidly without any identifiable precursors. Among all subtypes is heterogeneity in the biological behavior which has implications in patient prognosis and treatment especially for individualized therapies in the future. ","date":"2014-01-28","categories":"Endocrine System Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24468455","annotations":[{"name":"Ovarian cancer","weight":0.871875,"wikipedia_article":"http://en.wikipedia.org/wiki/Ovarian_cancer"},{"name":"Histology","weight":0.816757,"wikipedia_article":"http://en.wikipedia.org/wiki/Histology"},{"name":"Disease","weight":0.801843,"wikipedia_article":"http://en.wikipedia.org/wiki/Disease"},{"name":"Therapy","weight":0.801843,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Gynaecology","weight":0.74659,"wikipedia_article":"http://en.wikipedia.org/wiki/Gynaecology"},{"name":"Epithelium","weight":0.723286,"wikipedia_article":"http://en.wikipedia.org/wiki/Epithelium"},{"name":"Tumor","weight":0.71741,"wikipedia_article":"http://en.wikipedia.org/wiki/Tumor"},{"name":"Carcinoma","weight":0.71741,"wikipedia_article":"http://en.wikipedia.org/wiki/Carcinoma"},{"name":"Malignancy","weight":0.71741,"wikipedia_article":"http://en.wikipedia.org/wiki/Malignancy"},{"name":"Prognosis","weight":0.71741,"wikipedia_article":"http://en.wikipedia.org/wiki/Prognosis"},{"name":"Ovary","weight":0.713418,"wikipedia_article":"http://en.wikipedia.org/wiki/Ovary"},{"name":"Cancer","weight":0.709797,"wikipedia_article":"http://en.wikipedia.org/wiki/Cancer"},{"name":"Biology","weight":0.680329,"wikipedia_article":"http://en.wikipedia.org/wiki/Biology"},{"name":"Lesion","weight":0.660386,"wikipedia_article":"http://en.wikipedia.org/wiki/Lesion"},{"name":"Blood plasma","weight":0.585106,"wikipedia_article":"http://en.wikipedia.org/wiki/Blood_plasma"},{"name":"Evolution","weight":0.582424,"wikipedia_article":"http://en.wikipedia.org/wiki/Evolution"},{"name":"Clinical trial","weight":0.562436,"wikipedia_article":"http://en.wikipedia.org/wiki/Clinical_trial"},{"name":"Pathogenesis","weight":0.552466,"wikipedia_article":"http://en.wikipedia.org/wiki/Pathogenesis"},{"name":"Molecule","weight":0.435876,"wikipedia_article":"http://en.wikipedia.org/wiki/Molecule"},{"name":"Patient","weight":0.369573,"wikipedia_article":"http://en.wikipedia.org/wiki/Patient"},{"name":"Type I and type II errors","weight":0.329805,"wikipedia_article":"http://en.wikipedia.org/wiki/Type_I_and_type_II_errors"},{"name":"Homogeneity and heterogeneity","weight":0.321785,"wikipedia_article":"http://en.wikipedia.org/wiki/Homogeneity_and_heterogeneity"},{"name":"Behavior","weight":0.268449,"wikipedia_article":"http://en.wikipedia.org/wiki/Behavior"},{"name":"Precursor (chemistry)","weight":0.224556,"wikipedia_article":"http://en.wikipedia.org/wiki/Precursor_(chemistry)"},{"name":"Fiber","weight":0.131801,"wikipedia_article":"http://en.wikipedia.org/wiki/Fiber"},{"name":"Death","weight":0.0902143,"wikipedia_article":"http://en.wikipedia.org/wiki/Death"},{"name":"French language","weight":0.0391252,"wikipedia_article":"http://en.wikipedia.org/wiki/French_language"},{"name":"Molecular phylogenetics","weight":0.0300804,"wikipedia_article":"http://en.wikipedia.org/wiki/Molecular_phylogenetics"},{"name":"Dune","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Dune"},{"name":"Nicotinic acetylcholine receptor","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Nicotinic_acetylcholine_receptor"},{"name":"Grading (tumors)","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Grading_(tumors)"},{"name":"Type (biology)","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Type_(biology)"}]}
